Le Lézard
Classified in: Health
Subjects: PER, WOM

Maya Barsky, MD, MSCI Joins the Center for Advanced Reproductive Services as a Lead Physician


FARMINGTON, Conn., Dec. 12, 2023 /PRNewswire/ -- The Center for Advanced Reproductive Services, one of the leading family building programs in the country, announced Dr. Maya Barsky, reproductive endocrinologist, has joined as Lead Physician and Assistant Professor in the Department of Ob/Gyn at UConn School of Medicine. "I am excited to connect with patients and to get to know their stories to help build families for anyone interested in fertility treatment, fertility preservation, or understanding their fertility potential," said Barsky. "I am very fortunate to be a part of such a respected and successful program as the Center for Advanced Reproductive Services." Dr. Barsky is available to connect with patients via telehealth appointments effective immediately, with in-person appointments beginning in January 2024.

Dr. Barsky's special interests include polycystic ovarian syndrome (PCOS), reproductive surgery, diminished ovarian reserve, recurrent pregnancy loss, fertility preservation, and third-party reproduction. Dr. Barsky is board-certified in OB/GYN and Reproductive Endocrinology and Infertility (REI).  Prior to joining The Center for Advanced Reproductive Services, she was part of a private fertility practice in Austin, TX for several years.

Dr. Barsky earned a competitive combined undergraduate and medical degree at Brown University, completed her OB/GYN residency at Baystate Medical Center/Tufts University and her REI Fellowship at Baylor College of Medicine. She has a Master of Science degree in Clinical Investigation, received Open Door Professional Training from Family Equality, and is a fellow of the American College of Obstetricians and Gynecologists (ACOG) and the American Society for Reproductive Medicine (ASRM). She has won numerous awards for her work and is active in research to help advance the field and improve reproductive care.

About The Center for Advanced Reproductive Services
The Center for Advanced Reproductive Services has grown to be one of the largest in the state and one of the most successful family building programs in the country, responsible for the births of over 18,000 babies. Started in 1984, the Center offers many advanced techniques to help patients achieve successful pregnancies and has offices in Farmington, Hartford, New London, Branford and Middlebury, CT as well as a new location soon to open in the greater Springfield, MA area. The Center is an academic affiliate of UConn School of Medicine. For more information about the Center, visit www.uconnfertility.com.

SOURCE Center for Advanced Reproductive Services


These press releases may also interest you

at 16:30
Aptose Biosciences Inc. , a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2024, on Tuesday, May...

at 16:20
Cartesian Therapeutics, Inc. (the "Company"), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to four new employees. On May 1, 2024,...

at 16:15
Profound Medical Corp. ("Profound" or the "Company"), a...

at 16:10
Veracyte, Inc. , a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the annual meeting of the American Urological Association, show that the Decipher Prostate and Decipher Bladder Genomic Classifiers...

at 16:10
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the Compensation Committee of the company's Board of...

at 16:10
Injectsense Inc., a sensor-enabled digital health company,?announced that the ethics committee at the Centro de la Vision Clinic in Santiago, Chile, has approved a 20-patient study that will confirm safety and effectiveness of the company's...



News published on and distributed by: